NEW YORK, Feb. 22, 2017 /PRNewswire/ -- This report analyzes analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 30 companies including many key and niche players such as -
Read the full report: http://www.reportlinker.com/p02043303-summary/view-report.html
Advanced Medical Solutions Group plc
Coloplast A/S
Derma Sciences, Inc.
Lohmann & Rauscher GmbH
Misonix, Inc.
Read the full report: http://www.reportlinker.com/p02043303-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 Wound Debridement Products..............I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW.............. II-1 Wound Debridement - Market Overview II-1 Outlook.............. II-2 Chronic Wounds and Healthcare Burden II-3 Chronic Wounds: The Hard Numbers II-4 Prevalence and Incidence of Wounds - Select Statistics II-5 Table 1: Global Prevalence of Wounds (2015) (includes corresponding Graph/Chart)..............II-5
Table 2: Global Wound Care Market (2013): Percentage Breakdown of Share by Wound Type (includes corresponding Graph/Chart).............. II-6 Table 3: Healing Time by Type of Wound (in Days) II-6 Table 4: Incidence of Open Wounds in Select Countries (2013) (includes corresponding Graph/Chart) II-7 Growing Incidence of Hard to Heal Wounds Drives Market for Debridement Products..............II-7 Maintenance Debridement Sustains Adoption of Debridement Products/Techniques..............II-8 Competition.............. II-8 Leading Players in the Global Wound Debridement Products Market II-9 Wound Debridement Devices..............II-9
2. MARKET TRENDS AND DRIVERS..............II-10 Companies Gear up Focus on Advanced Products to Address Unmet Needs.............. II-10 NexoBrid.............. II-10 EscharEx.............. II-10 CPI Wound Therapy System..............II-10 Jetox Lavage Systems..............II-11 Monofilament Polyester Fibre Pads Buoy Growth in Mechanical Debridement Market.............. II-11 Plasma-Mediated Bipolar Radio Frequency Ablation Demonstrates Selective Ablation.............. II-12 Hydrosurgery Emerges as a Safe and Cost Effective Method II-12 Ultrasound Emerges as a Viable Option to Promote Improved Wound Healing.............. II-13 Focus Grows on More Effective and Less Painful Debridement Techniques for Burn Patients..............II-14 Debridement - An Important Prevention Tool for Chronic wounds in Diabetic Patients..............II-15 Honey as a Debridement Agent Gains Prominence II-16 Larvae Therapy Re-Emerges as an Effective Debridement Technology II-16 Increasing Focus on Reducing Hospital Stays Lends Traction II-17
3. GENERAL GROWTH DRIVERS..............II-18 Expanding Aging Population Spurs Demand II-18 Table 5: Elderly Population (60+ Years) as a Percentage of the Total Population: 2012 & 2050 (includes corresponding Graph/Chart).............. II-18
Table 6: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart) II-19
Table 7: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025E) & (2045-2050E) (includes corresponding Graph/Chart)..............II-20 Rising Prevalence of Diabetes Escalates Incidence of Chronic Wounds.............. II-20 Table 8: Worldwide Prevalence of Diabetes Mellitus by Region: 2013 & 2035 (includes corresponding Graph/Chart) II-22
Table 9: Incidence of Diabetes in Select Countries (2013 & 2035) (includes corresponding Graph/Chart) II-23 Increasing Obesity Levels Underpins Market Growth II-23 Table 10: World Obesity Prevalence (2015 & 2022): Percentage of Obese Population for Leading Ten Countries (includes corresponding Graph/Chart)..............II-24
4. PRODUCT OVERVIEW.............. II-25 Debridement.............. II-25 Purpose of Debridement..............II-26 Factors Influencing Debridement Decision II-26 Methods/Techniques of Debridement II-27 Autolytic Debridement..............II-27 Biologic Debridement..............II-27 Chemical/Enzymatic Debridement..............II-28 Mechanical Debridement..............II-28 Surgical Debridement..............II-29 Ultrasound.............. II-29 Types of Wounds.............. II-30 Acute Wounds.............. II-30 Surgical Incisions..............II-30 Burns.............. II-30 Chemical Burns.............. II-30 Electrical Burns.............. II-31 Flash Burns.............. II-31 Radiation Burns..............II-31 Thermal Burns.............. II-31 Chronic Wounds.............. II-31 Diabetic Ulcers.............. II-32 Venous Ulcers.............. II-32 Pressure Ulcers.............. II-32 Process of Wound Care..............II-32 Preparation.............. II-32 Controlling Bleeding..............II-32 Irrigation and Cleaning..............II-32 Closure.............. II-33 Infection Control.............. II-33 Wound Healing Process..............II-33 Injury.............. II-33 Inflammatory Response..............II-34 Characteristics.............. II-34 Coagulation Cascade..............II-34 Vasodilation.............. II-34 Cellular Activity.............. II-34 Debridement, Cell Growth and Healing II-35 Scarring.............. II-35 Abnormal Scarring.............. II-36 Fetal Wound Healing..............II-36
5. STRATEGIC CORPORATE DEVELOPMENTS..............II-37 Lohmann & Rauscher Introduces Debrisoft® Lolly II-37 Misonix Introduces SonicVac based on LFDCU Debridement Technology II-37 Topigenix™ Launches Topigenix™ Wound Care Line II-37 EscharEx® from MediWound Completes Phase II Clinical Trial II-37 Misonix Introduces Sonicone® Ultrasonic Debridement Procedure II-37 Lohmann & Rauscher Launches Debrisoft® Active Monofilament Debriding Device.............. II-37 BioMonde Introduces BioBag for treatment of Chronic Wounds II-38 Oculus Enters into Partnership with Genetix Biotech to Introduce Wound care Products in India II-38 MediWound Commences U.S. Phase 3 Trial with NexoBrid for Treatment of Thermal Burns..............II-38
6. FOCUS ON SELECT GLOBAL PLAYERS..............II-39 Advanced Medical Solutions Group plc (UK) II-39 Coloplast A/S (Denmark)..............II-39 Derma Sciences, Inc. (US)..............II-39 Lohmann & Rauscher GmbH (Germany) II-39 Misonix, Inc. (US)..............II-40 PuriCore plc (US).............. II-40 MediWound Ltd. (Israel)..............II-40 Smith & Nephew Plc (UK)..............II-41 Soering GmbH (Germany)..............II-41 Zimmer Biomet Holdings, Inc. (USA) II-41
7. GLOBAL MARKET PERSPECTIVE..............II-43 Table 11: World Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) II-43
Table 12: World Historic Review for Wound Debridement Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-44
Table 13: World 14-Year Perspective for Wound Debridement Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-45
III. MARKET
1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Current & Future Analysis..............III-1 Ageing Demographics and Growing Incidence of Chronic Diseases: Major Drivers..............III-1 Table 14: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart) III-2
Table 15: Prevalence of Hard-to-Heal Chronic Wounds in the US (2015): Percentage Breakdown of Share by Type (includes corresponding Graph/Chart)..............III-2 High Prevalence of Diabetes Drive Growth in Debridement Procedures.............. III-3 Table 16: US Diabetes Statistics (2013): Number of Diabetics by Gender (includes corresponding Graph/Chart) III-3
Table 17: US Diabetes Statistics (2013): Number of Diabetics by Age Group - 20-39 Years, 40-59 Years, and 60-79 Years (includes corresponding Graph/Chart) III-3
Table 18: Diabetes Prevalence Statistics in the US by Age Group and Gender (2013 & 2035) (includes corresponding Graph/Chart).............. III-4 Alarming Rise in Obesity to Drive Demand III-4 Table 19: US Adult Population by Weight Category: 2011-2015 (includes corresponding Graph/Chart) III-5
Table 20: US Adult Obesity Prevalence by Class (2011-2015): Percentage of Adult Population for Class I, Class II and Class III (includes corresponding Graph/Chart) III-6 Medicare Reimbursement..............III-6 Table 21: 2016 Medicare National Unadjusted Average Payment Rates for Debridement Procedures III-7 Strategic Corporate Developments III-8 Select Players.............. III-9 B.Market Analytics..............III-11 Table 22: US Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-11
Table 23: US Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-12
2. CANADA.............. III-13 A.Market Analysis.............. III-13 Current & Future Analysis..............III-13 Wound prevalence in Canada - A Statistical Review III-13 Table 24: Wound Prevalence in Canada (%) in (2012) (includes corresponding Graph/Chart) III-14
Table 25: Prevalence of Adult Diabetes in Canada by Gender (2010-2014): Number of Adult Males and Females Aged 12 Years and Over Diagnosed with Diabetes (In Thousands) (includes corresponding Graph/Chart) III-15
Table 26: Prevalence of Adult Diabetes in Canada by Age Group (2010-2014): Number of Adult Males and Females with Diabetes by Age Group (In Thousands) (includes corresponding Graph/Chart)..............III-15 B.Market Analytics..............III-16 Table 27: Canadian Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-16
Table 28: Canadian Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-17
3. JAPAN.............. III-18 A.Market Analysis.............. III-18 Current & Future Analysis..............III-18 B.Market Analytics..............III-18 Table 29: Japanese Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-18
Table 30: Japanese Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-19
4. EUROPE.............. III-20 A.Market Analysis.............. III-20 Current & Future Analysis..............III-20 High Wound Prevalence - A Strong Growth Driver III-20 Table 31: Prevalence of Chronic Wounds in Europe (2015): Percentage Breakdown of Share by Type (includes corresponding Graph/Chart)..............III-20 Diabetes Statistics in Europe..............III-21 Table 32: European Diabetes and Population Statistics (2013 & 2035).............. III-22 Select Players.............. III-22 B.Market Analytics..............III-24 Table 33: European Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-24
Table 34: European Historic Review for Wound Debridement Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-25
Table 35: European 14-Year Perspective for Wound Debridement Products by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-26
5. ASIA-PACIFIC.............. III-27 A.Market Analysis.............. III-27 Current & Future Analysis..............III-27 Wound Management Products - Market Overview III-27 Diabetes Prevalence in Asia..............III-27 Table 36: Diabetes Prevalence in Asia-Pacific (2015): Age-Adjusted (20-79) Comparative Prevalence of Adult Diabetes for Select Countries (includes corresponding Graph/Chart).............. III-28 Strategic Corporate Development III-28 B.Market Analytics..............III-29 Table 37: Asia-Pacific Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-29
Table 38: Asia-Pacific Historic Review for Wound Debridement Products by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-30
Table 39: Asia-Pacific 14-Year Perspective for Wound Debridement Products by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-31
6. LATIN AMERICA.............. III-32 A.Market Analysis.............. III-32 Current & Future Analysis..............III-32 Diabetes Statistics in Latin America III-32 Table 40: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for 20 Countries in the Region.............. III-33 B.Market Analytics..............III-34 Table 41: Latin American Recent Past, Current & Future Analysisfor Wound Debridement Products by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-34
Table 42: Latin American Historic Review for Wound Debridement Products by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-35
Table 43: Latin American 14-Year Perspective for Wound Debridement Products by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-36
7. REST OF WORLD.............. III-37 A.Market Analysis.............. III-37 Current & Future Analysis..............III-37 Strategic Corporate Development III-37 Select Player.............. III-37 B.Market Analytics..............III-38 Table 44: Rest of World Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-38
Table 45: Rest of World Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-39
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 30 (including Divisions/Subsidiaries - 39)
The United States (26) Canada (2) Europe (9) - Germany (2) - The United Kingdom (5) - Rest of Europe (2) Asia-Pacific (Excluding Japan) (1) Middle-East (1)
Read the full report: http://www.reportlinker.com/p02043303-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article